Newsroom
-
November 14 , 2023
Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3
Read more -
November 9 , 2023
HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer
Read more -
October 30 , 2023
Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate
Read more -
October 30 , 2023
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Read more -
October 12 , 2023
MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech on the development of a next-generation antibody-drug conjugate candidate (“ADC”), against Human Epidermal Growth Factor Receptor 3 (HER3)
Read more -
July 7 , 2021
Rare genetic variants confer largest increase in type 2 diabetes risk seen to date
- Scientists at the University of Cambridge have identified rare genetic variants—carried by one in 3,000 people—that have a larger impact on the risk of developing type 2 diabetes than any previously identified genetic effect.
Read more -
July 6 , 2021
Researchers discover way to improve immune response
- Melbourne researchers have identified a way to improve the immune response in the face of severe viral infections.
Read more -
July 5 , 2021
Structures discovered in brain cancer patients can help fight tumors
- Researchers at Uppsala University have discovered lymph node-like structures close to the tumour in brain cancer patients, where immune cells can be activated to attack the tumour. They also found that immunotherapy enhanced the formation of these structures in a mouse model. This discovery suggests new opportunities to regulate the anti-tumour response of t
Read more -
June 30 , 2021
Gene therapy breakthrough offers hope to children with rare and fatal brain disease
- Scientists and doctors at University College London Great Ormond Street Institute of Child Health (UCL GOS ICH) and Great Ormond Street Hospital (GOSH) have given hope of a gene therapy cure to children with a rare degenerative brain disorder called Dopamine Transporter Deficiency Syndrome (DTDS).
Read more -
June 29 , 2021
New components for antisense gene therapy show promise in treating spinal muscular atrophy
- Skoltech researchers and their colleagues from Russia and the UK investigated the safety and efficacy of new chemistry in antisense oligonucleotides used to treat spinal muscular atrophy (SMA), a debilitating genetic disease. Their results may lead to the development of drugs with less toxicity and fewer injections needed thanks to prolonged action. The pape
Read more -
June 28 , 2021
First clinical trial involving in vivo CRISPR human gene editing
- A team of researchers from Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals has conducted the first clinical trial involving in vivo CRISPR human gene editing.
Read more -
June 25 , 2021
Hard-working enzyme keeps immune cells in line
- Researchers at La Jolla Institute for Immunology (LJI) have shed light on a process in immune cells that may explain why some people develop cardiovascular diseases.
Read more